514 related articles for article (PubMed ID: 14601367)
1. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
[TBL] [Abstract][Full Text] [Related]
2. Preoperative epoetin alfa vs autologous blood donation in primary total knee arthroplasty.
Deutsch A; Spaulding J; Marcus RE
J Arthroplasty; 2006 Aug; 21(5):628-35. PubMed ID: 16877146
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
4. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction.
Lofthouse RA; Boitano MA; Davis JR; Jinnah RH
J South Orthop Assoc; 2000; 9(3):175-81. PubMed ID: 12135299
[TBL] [Abstract][Full Text] [Related]
5. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
Chun TY; Martin S; Lepor H
Urology; 1997 Nov; 50(5):727-32. PubMed ID: 9372883
[TBL] [Abstract][Full Text] [Related]
6. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
Patton J; Kuzur M; Liggett W; Miranda F; Varsos H; Porter L
Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018
[TBL] [Abstract][Full Text] [Related]
7. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
Scott SN; Boeve TJ; McCulloch TM; Fitzpatrick KA; Karnell LH
Laryngoscope; 2002 Jul; 112(7 Pt 1):1221-9. PubMed ID: 12169903
[TBL] [Abstract][Full Text] [Related]
8. Impact of erythropoietin on allogenic blood exposure in orthopedic surgery.
Santoro JE; Eastlack RK; Mirocha JM; Bugbee WD
Am J Orthop (Belle Mead NJ); 2007 Nov; 36(11):600-4. PubMed ID: 18075608
[TBL] [Abstract][Full Text] [Related]
9. Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy.
Granetto C; Ricci S; Martoni A; Pezzella G; Testore F; Mattioli R; Lampignano M; Tacconi F; Porrozzi S; Gasparini G; Mantovani G;
Oncol Rep; 2003; 10(5):1289-96. PubMed ID: 12883695
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
Stovall TG
J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
[TBL] [Abstract][Full Text] [Related]
12. Initiation of epoetin-alpha therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy: an open-label, multicenter study with randomized and nonrandomized treatment arms.
Glaspy JA; Charu V; Luo D; Moyo V; Kamin M; Wilhelm FE
Cancer; 2009 Mar; 115(5):1121-31. PubMed ID: 19170225
[TBL] [Abstract][Full Text] [Related]
13. Patients with and without rheumatoid arthritis benefit equally from preoperative epoetin-alpha treatment.
Slappendel R; Weber EW; Hémon YJ; Mähler S; Dalén T; Rouwet EF; van Os JJ; Vosmaer A; van der Ark PD
Acta Orthop; 2006 Aug; 77(4):677-83. PubMed ID: 16929448
[TBL] [Abstract][Full Text] [Related]
14. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty.
Stowell CP; Chandler H; Jové M; Guilfoyle M; Wacholtz MC
Orthopedics; 1999 Jan; 22(1 Suppl):s105-12. PubMed ID: 9927110
[TBL] [Abstract][Full Text] [Related]
15. Epoetin alfa plus autologous blood donation and normovolemic hemodilution in patients scheduled for orthopedic or vascular surgery.
Tryba M
Semin Hematol; 1996 Apr; 33(2 Suppl 2):34-6; discussion 37-8. PubMed ID: 8723580
[TBL] [Abstract][Full Text] [Related]
16. [Transfusion of recuperated blood in total knee arthroplasty].
Pitsaer E
Rev Chir Orthop Reparatrice Appar Mot; 2002 Dec; 88(8):777-89. PubMed ID: 12503019
[TBL] [Abstract][Full Text] [Related]
17. Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study.
Christodoulakis M; Tsiftsis DD;
Ann Surg Oncol; 2005 Sep; 12(9):718-25. PubMed ID: 16052276
[TBL] [Abstract][Full Text] [Related]
18. Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery.
Tryba M
Semin Hematol; 1996 Apr; 33(2 Suppl 2):22-4; discussion 25-6. PubMed ID: 8723577
[TBL] [Abstract][Full Text] [Related]
19. A randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplasty: effect on postoperative vigor and handgrip strength.
Keating EM; Callaghan JJ; Ranawat AS; Bhirangi K; Ranawat CS
J Arthroplasty; 2007 Apr; 22(3):325-33. PubMed ID: 17400086
[TBL] [Abstract][Full Text] [Related]
20. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
Ariganello O; Mancuso A; Di Molfetta M; Diana F; Beccaglia P; Cortesi E; De Marinis F
Lung Cancer; 2004 Oct; 46(1):119-24. PubMed ID: 15364140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
